SCHEMBL23609299

SCHEMBL23609299

Fc1cc(-c2nc(-c3ccc4ccccc4c3)nc(-c3ccc4ccccc4c3)n2)ccc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KIF11 P52732 1/20 0.40
CYP2A6 P11509 2/20 0.39
GSTP1 P09211 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
IDO1 P14902 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20597553 0.86 MEN1 (0.46) CYP1A2SMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL19534108 0.82 CYP2A6 (0.56) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL23606122 0.80 CYP2A6 (0.54) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL16861499 0.80 CYP1A2 (0.49) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL29528311 0.80 CYP1A2 (0.49) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL22578241 0.79 MEN1 (0.51) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL10051440 0.79 GSTP1 (0.52) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL23633460 0.79 ESR1 (0.58) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL30516195 0.79 ALDH1A1 (0.57) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL18646159 0.79 ALDH1A1 (0.57) CYP1A2SMN1; SMN2KDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223796-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-07-14 US disclosed
WO-2021129072-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223796-A1 ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE EXOC1, EXOC4, CHRM1 CYP1A2 350/4885SMN1; SMN2 2691/4885KDM4E 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.